Barbara Fingleton Ph.D. is an Associate Professor of Pharmacology and Surgery, and a member of the Cancer Biology Program at Vanderbilt University, Nashville, TN, USA. She received her graduate training and earned a Ph.D. at Dublin City University in Dublin, Ireland and then moved to the USA for postdoctoral training. She has been a tenure-track (now tenured) faculty member at Vanderbilt University since 2012. Her research is particularly focused on understanding the mechanisms of metastasis for solid tumors, and her work in this field has been by the US National Cancer Institute, biomedical research programs of the Dept. of Defense, and multiple foundations, including Susan G. Komen, METAvivor, and the Breast Cancer Alliance. Additionally, Dr. Fingleton is long-time member of the American Association for Cancer Research (AACR) and the Metastasis Research Society (MRS), the latter for which she served as a Board member and as secretary of the society.
Barbara Fingleton Ph.D. is an Associate Professor of Pharmacology and Surgery, and a member of the Cancer Biology Program at Vanderbilt University, Nashville, TN, USA. She received her graduate training and earned a Ph.D. at Dublin City University in Dublin, Ireland and then moved to the USA for postdoctoral training. She has been a tenure-track (now tenured) faculty member at Vanderbilt University since 2012. Her research is particularly focused on understanding the mechanisms of metastasis for solid tumors, and her work in this field has been by the US National Cancer Institute, biomedical research programs of the Dept. of Defense, and multiple foundations, including Susan G. Komen, METAvivor, and the Breast Cancer Alliance. Additionally, Dr. Fingleton is long-time member of the American Association for Cancer Research (AACR) and the Metastasis Research Society (MRS), the latter for which she served as a Board member and as secretary of the society.